ARA-290 is a non-hematopoietic erythropoietin-derived peptide engineered to selectively activate the innate repair receptor (IRR) without stimulating red blood cell production. In research environments, ARA-290 is examined for its role in neuroprotective signaling, tissue repair modulation, and inflammatory response pathways at the cellular level.
This compound is widely referenced in neuropathic pain models, small fiber neuropathy research, and innate immune repair studies, particularly where non-erythropoietic tissue-protective signaling pathways are of interest.
Research Focus Areas:
Innate repair receptor (IRR) activation and signaling
Neuropathic pain pathway modulation
Anti-inflammatory and tissue-protective research
Small fiber neuropathy modeling
Cytoprotective signaling pathway analysis
In-vitro neuroprotective compound studies
Specifications:
Purity: Independent third-party analytical verification in progress Form: Lyophilized peptide Solvent: Not included Use: Laboratory research only Storage: Refrigerate; protect from light and moisture Handling: Suitable for in-vitro experimentation and analytical applications Compliance: Not for human use. No medical or therapeutic claims.
Batch-specific analytical documentation is available in the COA tab.
